Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aisling Carr

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neurology|December 20, 2019
Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathyMahima Kapoor, Jennifer Spillane, Christina Englezou, et al.
European Journal of Neurology|July 15, 2022
Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathyMahima Kapoor, Aisling Carr, Martha Foiani, et al.
British Journal of Haematology|March 23, 2026
Front-line systemic treatment outcomes in POEMS syndromeOliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, et al.
Brain Communications|July 9, 2024
Pathologic <i>RFC1</i> repeat expansions do not contribute to the development of inflammatory neuropathiesSara Nagy, Aisling Carr, Magdalena Mroczek, et al.
The Oncologist|October 30, 2025
UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinomaSyed Hussain, Aisling Carr, Simon John Crabb, et al.
Neurology|March 12, 2017
Mutations in noncoding regions of <i>GJB1</i> are a major cause of X-linked CMTPedro J Tomaselli, Alexander M Rossor, Alejandro Horga, et al.
Neurology|July 2, 2020
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort studyStephen Keddie, David Foldes, Francisca Caimari, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
Cancers|December 30, 2025
Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare SystemBenjamin Schroeder, Prakrit Prasad, Ope Gbadegesin, et al.
Journal of the Peripheral Nervous System : JPNS|April 10, 2025
Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre SurveyYusuf A Rajabally, Christina Englezou, Grace Cluett, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neurology|December 20, 2019
Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathyMahima Kapoor, Jennifer Spillane, Christina Englezou, et al.
European Journal of Neurology|July 15, 2022
Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathyMahima Kapoor, Aisling Carr, Martha Foiani, et al.
British Journal of Haematology|March 23, 2026
Front-line systemic treatment outcomes in POEMS syndromeOliver Tomkins, Jahanzaib Khwaja, Shiwen Koay, et al.
Brain Communications|July 9, 2024
Pathologic <i>RFC1</i> repeat expansions do not contribute to the development of inflammatory neuropathiesSara Nagy, Aisling Carr, Magdalena Mroczek, et al.
The Oncologist|October 30, 2025
UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinomaSyed Hussain, Aisling Carr, Simon John Crabb, et al.
Neurology|March 12, 2017
Mutations in noncoding regions of <i>GJB1</i> are a major cause of X-linked CMTPedro J Tomaselli, Alexander M Rossor, Alejandro Horga, et al.
Neurology|July 2, 2020
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort studyStephen Keddie, David Foldes, Francisca Caimari, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
Cancers|December 30, 2025
Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare SystemBenjamin Schroeder, Prakrit Prasad, Ope Gbadegesin, et al.
Journal of the Peripheral Nervous System : JPNS|April 10, 2025
Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre SurveyYusuf A Rajabally, Christina Englezou, Grace Cluett, et al.
Pageof 3